Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

NCT07232069 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT07232069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07232069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Lead sponsor
Duke University
Phase
Phase 3
Overall status
Recruiting
Start date
July 21, 2026
Completion date
July 31, 2031
Enrollment
1,500 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease progression, coronary artery disease risk factors multiple, premature atherosclerosis, prevention & control